QuidelOrtho Corporation (LON:0A55)
43.50
-0.14 (-0.31%)
Jan 31, 2025, 6:48 PM GMT
QuidelOrtho Revenue
In the year 2025, QuidelOrtho had annual revenue of $2.73B USD, down -1.89%. QuidelOrtho had revenue of $723.60M in the quarter ending December 28, 2025, with 2.23% growth.
Revenue
$2.73B
Revenue Growth
-1.89%
P/S Ratio
0.58
Revenue / Employee
$413.67K
Employees
6,600
Market Cap
1.18B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2025 | 2.73B | -52.70M | -1.89% |
| Dec 29, 2024 | 2.78B | -214.90M | -7.17% |
| Dec 31, 2023 | 3.00B | -268.20M | -8.21% |
| Jan 1, 2023 | 3.27B | 1.57B | 92.28% |
| Jan 2, 2022 | 1.70B | 36.90M | 2.22% |
| Jan 3, 2021 | 1.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Spire Healthcare Group | 1.55B |
| CVS Group | 673.20M |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |
QuidelOrtho News
- 4 weeks ago - Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now - Nasdaq
- 7 weeks ago - Notable Two Hundred Day Moving Average Cross - QDEL - Nasdaq
- 2 months ago - Innovating Diagnostics and What's Next - PRNewsWire
- 2 months ago - Insider Buying: Ann Rhoads Acquires Shares of QuidelOrtho Corp (QDEL) - GuruFocus
- 2 months ago - Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs - The Motley Fool
- 2 months ago - QuidelOrtho Corp at Citi Global Healthcare Conference Transcript - GuruFocus
- 2 months ago - QuidelOrtho Corporation (QDEL) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Monday 11/24 Insider Buying Report: QDEL, MTCH - Nasdaq